Insider · CIK 0001476151
Enrique A Conterno
Files at KYNB (FIBROGEN INC). First filing Dec 9, 2022, latest Mar 10, 2023.
In brief
Enrique A Conterno files SEC Form 4 as CEO and director at KYNB (FIBROGEN INC). Since Dec 9, 2022, Enrique A Conterno has reported 0 open-market buys worth $0 and 3 open-market sells worth $1.2M, the latest filed on Mar 10, 2023.
A track record needs three past buys with six months of prices behind them; Enrique A Conterno has 0, so none is measured yet.
The newest scored trade: sold $1.2M of KYNB on Mar 8, 2023, filed Mar 10, 2023, scored 63 (notable).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
KYNB: FIBROGEN INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 63Notable | FIBROGEN INC | $1.2M 56,261 shares | -15% | +165% from low-16% from high | |
| 38Weak | FIBROGEN INC | $31k 1,538 shares | -1% | +149% from low0% from high | |
| 46Moderate | FIBROGEN INC | $40k 2,543 shares | -1% | +90% from low-15% from high |
Transactions
Every row this insider has filed, 10 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 8, 2023 | KYNB FIBROGEN INC | SOpen-market sale Common Stock | -24,672 | $21.16 | $522k | 356,111 | Mar 10, 2023 |
| Mar 8, 2023 | KYNB FIBROGEN INC | AGrant or award Common Stock | +23,120 | $0.00 | $0 | 379,231 | Mar 10, 2023 |
| Mar 8, 2023 | KYNB FIBROGEN INC | AGrant or award Common Stock | +37,229 | $0.00 | $0 | 416,460 | Mar 10, 2023 |
| Mar 10, 2023 | KYNB FIBROGEN INC | SOpen-market sale Common Stock | -12,103 | $20.20 | $244k | 404,357 | Mar 10, 2023 |
| Mar 10, 2023 | KYNB FIBROGEN INC | SOpen-market sale Common Stock | -19,486 | $20.20 | $394k | 384,868 | Mar 10, 2023 |
| Feb 21, 2023 | KYNB FIBROGEN INC | AGrant or award Common Stock | +85,300 | $0.00 | $0 | 380,783 | Feb 23, 2023 |
| Feb 21, 2023 | KYNB FIBROGEN INC | AGrant or award Stock Option (Right to Buy)derivative | +143,100 | $0.00 | $0 | 143,100 | Feb 23, 2023 |
| Jan 6, 2023 | KYNB FIBROGEN INC | SOpen-market sale Common Stock | -1,538 | $19.95 | $31k | 295,483 | Jan 10, 2023 |
| Dec 8, 2022 | KYNB FIBROGEN INC | SOpen-market sale Common Stock | -2,543 | $15.79 | $40k | 297,020 | Dec 9, 2022 |
| Oct 6, 2022 | KYNB FIBROGEN INC | FTax withholding Common Stock | -1,296 | $14.26 | $18k | 299,563 | Oct 11, 2022 |
Questions about Enrique A Conterno
Answered from the filings on this page, as of the latest one.
Is Enrique A Conterno buying or selling?
Not in the last 12 months. Enrique A Conterno's latest open-market trade on SEC Form 4 was sold $1.2M of KYNB on Mar 8, 2023.
How did Enrique A Conterno's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Enrique A Conterno has 0.
Where does Enrique A Conterno file Form 4?
Enrique A Conterno has filed Form 4 at KYNB (FIBROGEN INC) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.